CLINICAL TRIALS PROFILE FOR DEURUXOLITINIB PHOSPHATE
✉ Email this page to a colleague
All Clinical Trials for DEURUXOLITINIB PHOSPHATE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT05467722 ↗ | Study to Assess the Effect of Hepatic Impairment on the Pharmacokinetics of CTP-543 | Recruiting | Concert Pharmaceuticals | Phase 1 | 2022-06-01 | This is an open-label, single-dose, single-period, parallel group designed study to determine the effect of mild and moderate hepatic impairment on the pharmacokinetics (PK) of CTP-543 and its major metabolites following administration of a single 12 mg oral dose of CTP-543. |
| NCT05468749 ↗ | Study to Assess the Effect of Renal Impairment on the Pharmacokinetics of CTP-543 | Recruiting | Concert Pharmaceuticals | Phase 1 | 2022-06-06 | This is an open-label, single-dose, sequentially designed, single-period study to determine the effect of moderate renal impairment on the pharmacokinetics (PK) of CTP-543 and its major metabolites following administration of a single 12 mg oral dose of CTP-543. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for DEURUXOLITINIB PHOSPHATE
Condition Name
Clinical Trial Locations for DEURUXOLITINIB PHOSPHATE
Trials by Country
Clinical Trial Progress for DEURUXOLITINIB PHOSPHATE
Clinical Trial Phase
Clinical Trial Sponsors for DEURUXOLITINIB PHOSPHATE
Sponsor Name
